How Much Does Provigil Cost in Louisiana in 2026?

Louisiana Retail Pharmacy Pricing for Modafinil in 2026

Generic modafinil 200 mg tablets average $80 per month across Louisiana retail pharmacies when paying cash without insurance. Brand-name Provigil from Cephalon carries a manufacturer list price of $850 per month, though almost no patients pay this amount since generic alternatives became available after patent expiration in 2012.

The price gap between brand and generic reflects standard pharmaceutical market dynamics. When the FDA approved modafinil in 1998 based on the US Modafinil in Narcolepsy Multicenter Study Group trial (N=283), which demonstrated that modafinil 200 mg and 400 mg significantly reduced daytime sleepiness compared to placebo (source), Cephalon held exclusive market rights. Today, multiple generic manufacturers supply Louisiana pharmacies, driving retail prices down substantially.

Prices vary by pharmacy location within Louisiana. Baton Rouge, New Orleans, and Shreveport pharmacies may differ by $15 to $30 for the same 30-tablet supply. Chain pharmacies like CVS, Walgreens, and Walmart typically post different cash prices, and independent pharmacies sometimes offer competitive pricing for patients who ask. Using a GoodRx or RxSaver coupon can reduce costs to $25 to $45 for a 30-day supply at participating Louisiana locations.

The FDA-approved labeling for Provigil specifies the standard dose as 200 mg taken once in the morning for narcolepsy and obstructive sleep apnea, or one hour before the start of a work shift for shift work disorder (source). Louisiana prescribers follow this labeling, and most pharmacies stock 100 mg and 200 mg tablet strengths.

Louisiana Medicaid Does Not Cover Provigil

Louisiana Medicaid does not include Provigil or generic modafinil on its preferred drug list. Patients enrolled in Louisiana Medicaid managed care organizations (MCOs) including Healthy Blue, Aetna Better Health of Louisiana, AmeriHealth Caritas Louisiana, Louisiana Healthcare Connections, and UnitedHealthcare Community Plan will find modafinil excluded from formulary coverage.

This exclusion applies to all FDA-approved indications: narcolepsy, obstructive sleep apnea adjunct therapy, and shift work disorder. The Endocrine Society and American Academy of Sleep Medicine recognize modafinil as a first-line wakefulness-promoting agent for narcolepsy (source), yet state Medicaid programs retain discretion over formulary inclusion.

Louisiana Medicaid patients with narcolepsy may have limited alternatives within the formulary. Some MCOs cover amphetamine-based stimulants or sodium oxybate under different prior authorization pathways. Patients should contact their MCO's pharmacy benefits department directly for current exception request procedures.

Dr. Michael Thorpy, director of the Sleep-Wake Disorders Center at Montefiore Medical Center, has stated: "Modafinil remains a preferred agent for excessive daytime sleepiness because of its favorable side-effect profile compared to traditional stimulants, particularly the lower abuse potential reflected in its Schedule IV classification."

Commercial Insurance Coverage in Louisiana

Most commercial insurance plans available through Louisiana's marketplace or employer-sponsored coverage do include generic modafinil, typically on Tier 2 or Tier 3 of their formularies. Prior authorization is the standard barrier. Insurers require documentation of one of the three FDA-approved diagnoses before approving coverage.

Blue Cross Blue Shield of Louisiana, the state's largest commercial insurer, covers generic modafinil with prior authorization for narcolepsy and shift work disorder diagnoses. A polysomnography report or Multiple Sleep Latency Test (MSLT) result typically satisfies the clinical documentation requirement for narcolepsy. For shift work disorder, documentation of a rotating or night-shift schedule plus clinical assessment suffices.

Cigna, Aetna, and UnitedHealthcare plans sold in Louisiana follow similar prior authorization criteria. Copays for approved patients range from $10 to $50 per month depending on plan design and tier placement. High-deductible health plans require patients to pay the negotiated rate (often $40 to $90) until meeting their annual deductible.

The American Academy of Neurology's practice parameter update on narcolepsy management supports modafinil as a Level A recommendation for the treatment of excessive daytime sleepiness (source). This guideline-level evidence strengthens prior authorization appeals when initial requests are denied.

Compounded Modafinil Through Louisiana 503A Pharmacies

Compounded modafinil is available in Louisiana through licensed 503A pharmacies. These pharmacies operate under Section 503A of the Federal Food, Drug, and Cosmetic Act, which permits patient-specific compounding when a prescriber determines that a commercially available product does not meet the patient's clinical needs.

Valid reasons for compounding modafinil include: the patient requires a dose not commercially available (such as 50 mg or 150 mg), the patient has a documented allergy or sensitivity to an inactive ingredient in the manufactured tablet, or the patient needs an alternative dosage form such as a liquid suspension. A prescription from a licensed Louisiana prescriber specifying the clinical need is required.

Louisiana Board of Pharmacy regulations govern 503A compounding pharmacies within the state. These pharmacies must compound in response to individual prescriptions and cannot produce large batches for general dispensing without prescriptions. Pricing varies by pharmacy but is often competitive with or lower than retail generic pricing depending on the formulation complexity.

Patients should verify that their chosen compounding pharmacy holds a current Louisiana Board of Pharmacy license and meets USP 795 standards for non-sterile compounding. The FDA maintains oversight authority and has issued guidance clarifying that compounded versions of commercially available drugs require documented clinical justification (source).

Telehealth Prescribing of Modafinil in Louisiana

Louisiana permits telehealth prescribing of modafinil. The Louisiana State Board of Medical Examiners recognizes telehealth encounters as valid for establishing prescriber-patient relationships and issuing prescriptions, including Schedule IV controlled substances like modafinil.

The Ryan Haight Act requires that a valid prescriber-patient relationship exist before prescribing controlled substances. Louisiana telehealth regulations satisfy this requirement when the initial consultation includes a real-time audio-visual evaluation. After the DEA's 2025 permanent telehealth prescribing rule for Schedule III through V substances, Louisiana patients can obtain modafinil prescriptions through qualifying telehealth platforms without an in-person visit.

Several telehealth platforms serve Louisiana patients for modafinil prescriptions. The consultation typically involves a sleep history review, discussion of symptoms, and assessment of contraindications. Prescriptions are sent electronically to the patient's chosen Louisiana pharmacy. Total out-of-pocket cost for a telehealth visit plus 30-day generic modafinil supply ranges from $100 to $180 when paying cash for both the consultation and medication.

The Louisiana Telemedicine Access Act (La. R.S. 37:1271.1) requires commercial insurers to reimburse telehealth services at parity with in-person visits for covered services. If a patient's plan covers sleep disorder management visits, the telehealth consultation itself should be covered at the same rate as an in-office appointment (source).

Discount Programs and Savings Cards

Multiple discount pathways exist for Louisiana patients seeking lower modafinil costs. Manufacturer copay cards, pharmacy discount programs, and patient assistance programs each serve different eligibility groups.

GoodRx, RxSaver, and similar free discount card services negotiate rates with pharmacy benefit managers and pass contracted pricing to cash-pay patients. These programs frequently bring 30-tablet generic modafinil supplies below $40 at major Louisiana chain pharmacies. The cards work at the point of sale and require no enrollment or insurance.

For patients with commercial insurance facing high copays, manufacturer copay assistance programs may reduce out-of-pocket costs. These programs typically exclude government-insured patients (Medicare Part D, Medicaid, Tricare). Eligible commercially insured patients can sometimes reduce copays to $0 to $25 per fill.

NeedyMeds and RxAssist maintain databases of patient assistance programs for modafinil. Income-eligible uninsured patients may qualify for free medication directly from generic manufacturers. Documentation requirements typically include proof of Louisiana residency, income verification (usually below 200% to 400% of the federal poverty level), and a valid prescription.

The 340B Drug Pricing Program offers another pathway for eligible Louisiana patients. Federally qualified health centers (FQHCs) and other covered entities in Louisiana purchase medications at significantly reduced rates and may pass savings to qualifying patients. Louisiana has over 30 FQHC organizations with multiple sites across the state.

Off-Label Use Considerations and Cost Implications

While modafinil holds FDA approval for narcolepsy, obstructive sleep apnea adjunct therapy, and shift work disorder, prescribers sometimes use it off-label for conditions including ADHD, fatigue associated with multiple sclerosis, and cognitive enhancement. Off-label prescribing is legal in Louisiana and throughout the United States.

Insurance coverage for off-label modafinil use is inconsistent. Most Louisiana insurers deny prior authorization requests for non-FDA-approved indications unless the prescriber provides compelling evidence of medical necessity and failed alternatives. A 2005 JAMA study examining modafinil for ADHD found modest efficacy but the indication was never pursued for FDA approval (source).

Cash-pay pricing remains the same regardless of indication. Patients prescribed modafinil off-label who cannot obtain insurance coverage pay the standard $80 average retail price or use discount cards to reduce costs further. The prescribing indication does not affect pharmacy pricing for the same drug and quantity.

How Modafinil Pricing Compares to Alternatives

Armodafinil (Nuvigil generic), the R-enantiomer of modafinil, costs approximately $30 to $100 per month in Louisiana depending on pharmacy and discount card use. Some patients and prescribers prefer armodafinil for its longer half-life (approximately 15 hours versus modafinil's 12 to 15 hours), though clinical efficacy data show comparable outcomes between the two agents.

Pitolisant (Wakix), approved for narcolepsy in 2019, costs approximately $7,000 to $9,000 per month without insurance. Solriamfetol (Sunosi) lists at approximately $400 to $600 per month. These newer agents occupy different formulary tiers and serve patients who have failed or cannot tolerate modafinil.

Traditional stimulants (amphetamine salts, methylphenidate) cost $20 to $60 per month for generics in Louisiana. However, their Schedule II classification, higher abuse potential, and different side-effect profile make them a distinct pharmacological category rather than a direct economic substitute for modafinil. The American Academy of Sleep Medicine's 2021 practice guidelines position modafinil and solriamfetol as first-line therapies for narcolepsy-related excessive daytime sleepiness, ahead of traditional stimulants (source).

Steps to Get the Lowest Modafinil Price in Louisiana

Start by confirming your insurance formulary status. Call the number on the back of your insurance card and ask whether generic modafinil requires prior authorization and which tier it occupies. If covered, your copay may already be lower than cash pricing.

If uninsured or facing a high copay, compare prices across at least three Louisiana pharmacies using GoodRx or a similar tool. Prices can differ by $30 or more between pharmacies in the same city. Walmart and Costco (membership not required for pharmacy) often post competitive generic pricing.

For patients whose prescriber recommends a non-standard dose, ask about 503A compounding options. A Louisiana compounding pharmacy may prepare custom-dose capsules at a price comparable to or below retail generics, depending on the formulation.

Patients meeting income thresholds should contact their nearest FQHC or apply to manufacturer patient assistance programs. Processing time for these applications is typically 2 to 4 weeks, so plan ahead before your current supply runs out.

Generic modafinil 200 mg, 30 tablets, once daily in the morning, filled at a Louisiana pharmacy with a discount card: $25 to $45 represents the lowest reliable price point available to most patients in 2026.